Pennsylvania legislation · 2025-2026 Regular Session
Pennsylvania HB2267: An Act amending the act of March 10, 1949 (P.L.30, No.14), known as the Public School Code of 1949, in school health services, providing for possession and use of prescribed pancreatic enzyme replacement therapy.
Status: In committee, March 9, 2026
What the bill says
An act relating to the public school system, including certain provisions applicable as well to private and parochial schools; amending, revising, consolidating and changing the laws relating thereto," in school health services, providing for possession and use of prescribed pancreatic enzyme replacement therapy.
From the introduced text, March 9, 2026:
An act relating to the public school system, including certain provisions applicable as well to private and parochial schools; amending, revising, consolidating and changing the laws relating thereto," in school health services, providing for possession and use of prescribed pancreatic enzyme replacement therapy. The General Assembly of the Commonwealth of Pennsylvania hereby enacts as follows: Section 1. The act of March 10, 1949 (P.L.30, No.14), known as the Public School Code of 1949, is amended by adding a section to read: Section 1414.13. Possession and Use of Prescribed Pancreatic Enzyme Rep lacement Therapy .-- (a) A school entity shall require the parent or guardian of a secondary school student who has pancreatic insufficiency or cystic fibrosis, who has been prescribed PERT and who requests that the student possess and self-administer PERT in a school setting to provide all of the following: (1) A signed and written order from the student's health care practitioner that: (i) states the name and dose of PERT , the times when PERT is to be taken, the period for which use is authorized and the diagnosis or reason PERT is needed; and (ii) identifies any potential serious reaction to PERT , describes the appropriate emergency response and states whether the student is competent to self-administer PERT and able to follow proper safety precautions for handling …
Sponsors
- Tarik Khan (D, 194) · primary sponsor
- Jeremy Shaffer (R, 28)
- Benjamin Waxman (D, 182)
- Carol Hill-Evans (D, 95)
- Benjamin Sanchez (D, 153)
- Robert FREEMAN (D, 136)
- Tarah Probst (D, 189)
- Andrew Kuzma (R, 39)
- Ed Neilson (D, HD-174)
- Steven Malagari (D, 53)
- Patrick Gallagher (D, 173)
- Eddie Pashinski (D, 121)
Latest actions
- : Referred to EDUCATION, March 9, 2026
Subjects: EDUCATION
Common questions
- What is HB2267?
- HB2267 is a bill in the Pennsylvania Legislature (2025-2026 Regular Session): An Act amending the act of March 10, 1949 (P.L.30, No.14), known as the Public School Code of 1949, in school health services, providing for possession and use of prescribed pancreatic enzyme replacement therapy.
- What does HB2267 do?
- In its own words: An act relating to the public school system, including certain provisions applicable as well to private and parochial schools; amending, revising, consolidating and changing the laws relating thereto," in school health services, providing for possession and use of prescribed pancreatic enzyme replacement therapy.
- What is the status of HB2267?
- In committee as of March 9, 2026. Latest action: Referred to EDUCATION, March 9, 2026 (March 9, 2026).
- Who sponsored HB2267?
- Tarik Khan (D, 194), with 11 co-sponsors.
- Where is the official record for HB2267?
- On the Pennsylvania Legislature website: https://www.palegis.us/legislation/bills/2025/hb2267
Source: official Pennsylvania record. Tracked by Delilah, AI for legislation across all 50 states and Congress.